Ticker archive · $CTXR

$CTXR Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $CTXR — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$CTXR – Citius Oncology Reports 120% QoQ Unit Shipment Growth for LYMPHIR in Fiscal Q4

Citius Pharmaceuticals, Inc.
· SEC_8K · All $CTXR
?? Positive AI Sentiment (+4.5 / 10)
  • Wholesaler purchases rose to 792 units in Q4 from 360 in Q3 (+120% QoQ).
  • 54 institutions have ordered LYMPHIR to date, up from 44 in mid-August.
  • Preliminary commercial update issued via Item 2.02 by majority-owner Citius Pharma.
Observed market reaction after signal
Peak +1.98%